- Home
- KALA vs HUIZ Comparison
KALA vs HUIZ Comparison
Compare KALA & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- HUIZ
- Stock Information
- Founded
- KALA 2009
- HUIZ 2006
- Country
- KALA United States
- HUIZ China
- Employees
- KALA N/A
- HUIZ N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- KALA Health Care
- HUIZ Finance
- Exchange
- KALA Nasdaq
- HUIZ Nasdaq
- Market Cap
- KALA 26.2M
- HUIZ 25.3M
- IPO Year
- KALA 2017
- HUIZ 2020
- Fundamental
- Price
- KALA $14.65
- HUIZ $2.62
- Analyst Decision
- KALA Strong Buy
- HUIZ Hold
- Analyst Count
- KALA 2
- HUIZ 1
- Target Price
- KALA $13.50
- HUIZ $2.30
- AVG Volume (30 Days)
- KALA 205.1K
- HUIZ 29.6K
- Earning Date
- KALA 08-08-2025
- HUIZ 09-12-2025
- Dividend Yield
- KALA N/A
- HUIZ N/A
- EPS Growth
- KALA N/A
- HUIZ N/A
- EPS
- KALA N/A
- HUIZ N/A
- Revenue
- KALA N/A
- HUIZ $168,454,627.00
- Revenue This Year
- KALA N/A
- HUIZ $11.94
- Revenue Next Year
- KALA N/A
- HUIZ $8.15
- P/E Ratio
- KALA N/A
- HUIZ N/A
- Revenue Growth
- KALA N/A
- HUIZ 1.28
- 52 Week Low
- KALA $2.92
- HUIZ $1.50
- 52 Week High
- KALA $15.80
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- KALA 82.92
- HUIZ 60.05
- Support Level
- KALA $8.50
- HUIZ $2.25
- Resistance Level
- KALA $15.80
- HUIZ $2.63
- Average True Range (ATR)
- KALA 1.25
- HUIZ 0.13
- MACD
- KALA 0.55
- HUIZ 0.02
- Stochastic Oscillator
- KALA 86.77
- HUIZ 84.18
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.